Miguel Prudêncio's team at iMM, the Radboud University Medical Center (Radboudumc) in the Netherlands and PATH in Seattle, Washington will collaborate to test a new approach to malaria vaccine development in humans for the first time.
Miguel Prudêncio's team at iMM, the Radboud University Medical Center (Radboudumc) in the Netherlands and PATH in Seattle, Washington will collaborate to test a new approach to malaria vaccine development in humans for the first time.